Journal Information
Share
Share
Download PDF
More article options
Corrigendum
Full text access
Available online 7 June 2024
Corrigendum to “Chronic respiratory diseases as a risk factor for herpes zoster infection” [Arch Bronconeumol. 2024;59(12):797–804]
Visits
252
Diego Morenaa,b,
Corresponding author
diegomorenavalles6@gmail.com

Corresponding author.
, Sara Lumbrerasc, José Miguel Rodríguezd, Carolina Camposa, María Castilloa, María Benavente, José Luis Izquierdoa,f
a Servicio de Neumología, Hospital Universitario de Guadalajara, Guadalajara, Spain
b Programa de Doctorado en Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain
c Universidad Pontificia Comillas – IIT, Spain
d Servicio de Neumología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
e SAVANA, Madrid, Spain
f Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá, Madrid, Spain
Related content
Arch Bronconeumol. 2023;59:797-80410.1016/j.arbres.2023.08.010
Diego Morena, Sara Lumbreras, José Miguel Rodríguez, Carolina Campos, María Castillo, María Benavent, José Luis Izquierdo
This item has received
Article information
Full Text
Download PDF
Statistics
Tables (2)
Table 5. Main non-respiratory comorbidities, defined as risk factors, and their prevalence in the population with herpes zoster, with and without PHN.
Table 6. Main respiratory pathologies and their prevalence in the population with herpes zoster, with and without PHN.
Show moreShow less
Full Text

In the paper “Chronic respiratory diseases as a risk factor for herpes zoster infection” (D. Morena, S. Lumbreras, J.M. Rodríguez et al. Archivos de Bronconeumología 59 (2023) 797–804), errors have been detected in Tables 5 and 6, so we are reproducing them as they should have been published.

Table 5.

Main non-respiratory comorbidities, defined as risk factors, and their prevalence in the population with herpes zoster, with and without PHN.

  Herpes zoster  Postherpetic neuralgia  No postherpetic neuralgia  P  OR (95%) 
Arterial hypertension
Yes  16867  53.1  1501  8.9  15366  91.1  <0.001  1.2 (1.1–1.3) 
No  14898  46.9  1175  7.9  13723  92.1     
Dyslipidemia
Yes  12547  39.5  1167  9.3  11380  90.7  <0.001  1.2 (1.1–1.3) 
No  19218  60.5  1509  7.9  17709  92.1     
Diabetes mellitus
Yes  8417  26.5  976  11.6  7441  88.4  <0.001  1.7 (1.5–1.8) 
No  23348  73.5  1700  7.3  21648  92.7     
Depression
Yes  5802  18.3  604  10.4  5198  89.6  <0.001  1.3 (1.2–1.4) 
No  25963  81.7  2072  8.0  23891  92.0     
Ischemic heart disease
Yes  3691  11.6  207  5.6  3484  94.4  <0.001  0.6 (0.5–0.7) 
No  28074  88.4  2469  8.8  25605  91.2     
Rheumatoid arthritis
Yes  602  1.9  77  12.8  525  87.2  <0.001  1.6 (1.3–2.1) 
No  31163  98.1  2599  8.3  28564  91.7     
Inflammatory bowel disease
Yes  450  1.4  33  7.3  417  92.7  >0.05  0.9 (0.6–1.2) 
No  31315  98.6  2643  8.4  28672  91.6     
Stroke
Yes  2673  8.4  328  12.3  2345  87.7  <0.001  1.6 (1.4–1.8) 
No  29092  91.6  2348  8.1  26744  91.9     
Osteoporosis
Yes  3262  10.3  410  12.5  2852  87.5  <0.001  1.7 (1.5–1.9) 
No  28503  89.7  2266  8.0  26237  92.0     
Table 6.

Main respiratory pathologies and their prevalence in the population with herpes zoster, with and without PHN.

  Herpes zoster  Postherpetic neuralgia  No postherpetic neuralgia  P  OR (95%) 
Asthma
Yes  2497  7.9  231  9.3  2266  90.7  >0.05  1.1 (0.9–1.3) 
No  29268  92.1  2445  8.4  26823  91.6     
COPD
Yes  2784  8.8  386  13.9  2398  86.1  <0.001  1.9 (1.7–2.1) 
No  28981  91.2  2290  7.9  26691  92.1     
OSA
Yes  2174  6.8  252  11.6  1922  88.4  <0.001  1.5 (1.3–1.7) 
No  29591  93.2  2424  8.2  27167  91.8     
Lung cancer
Yes  488  1.5  59  12.1  429  87.9  <0.001  1.5 (1.1–1.9) 
No  31277  98.5  2617  8.4  28660  91.6     
Copyright © 2023. SEPAR
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?